1. Home
  2. CCC vs IDYA Comparison

CCC vs IDYA Comparison

Compare CCC & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCC Intelligent Solutions Holdings Inc.

CCC

CCC Intelligent Solutions Holdings Inc.

N/A

Current Price

$5.31

Market Cap

3.6B

Sector

Technology

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$28.81

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCC
IDYA
Founded
1980
2015
Country
United States
United States
Employees
2185
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
CCC
IDYA
Price
$5.31
$28.81
Analyst Decision
Buy
Strong Buy
Analyst Count
8
16
Target Price
$8.94
$52.86
AVG Volume (30 Days)
11.6M
1.5M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
N/A
$218,710,000.00
Revenue This Year
$10.22
N/A
Revenue Next Year
$8.58
$201.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$4.58
$16.82
52 Week High
$8.68
$39.28

Technical Indicators

Market Signals
Indicator
CCC
IDYA
Relative Strength Index (RSI) 48.42 39.72
Support Level $4.86 $26.05
Resistance Level $6.34 $34.76
Average True Range (ATR) 0.29 1.38
MACD 0.02 -0.33
Stochastic Oscillator 58.66 13.64

Price Performance

Historical Comparison
CCC
IDYA

About CCC CCC Intelligent Solutions Holdings Inc.

CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: